Background Visceral leishmaniasis is an important infection in patients infected with human
immunodeficiency virus and living in areas endemic for Leishmania sp. Leishmaniasis …

Background The changes that HIV coinfection can induce in clinical symptoms, response to
treatment and prognosis of visceral Leishmaniasis (VL) are not well known. Method We …

Leishmaniasis is considered an emerging opportunistic disease in human
immunodeficiency virus (HIV)–infected patients who have considerably variable clinical …

Visceral leishmaniasis is rare in western Europe, but may be life-threatening in
immunocompromised patients. It is therefore important to understand the incidence of the …

Cases of visceral leishmaniasis (VL) in HIV-positive individuals have been reported from
most areas of the world where the geographical distributions of the two infections overlap …

Visceral leishmaniasis is increasingly reported in immunocompromised patients, including
patients with AIDS. We report a case of visceral leishmaniasis in an AIDS patient who …

A retrospective study was conducted in France in 1998 to determine the clinical features of
visceral leishmaniasis (VL) in 91 patients infected cocomitantly with human …

We report a case of visceral leishmaniasis in a human immunodeficiency virus (HIV)-
infected 37-year-old Thai fisherman who presented with nephritonephrotic syndrome, fever …

Visceral leishmaniasis is an anthropozoonosis endemic in the south of France. Its
occurrence among patients infected with human immunodeficiency virus (HIV), in whom it …

Visceral leishmaniasis (VL) due to Leishmania infantum is endemic in Southern France and
can be considered as an opportunistic infection in patients with acquired immunodeficiency …